Docusign
DOCU
$84.41
+3.60%
DocuSign operates the Agreement Cloud, a cloud-based software suite that lets organizations prepare, sign, act on, and manage agreements, with legally binding e-signature as its foundational product; it competes in the application software industry alongside workflow, contract lifecycle management, and identity-verification vendors. The company is the category-defining brand in e-signature with an installed base spanning enterprises, small businesses, and developers via its API platform, but it is no longer a hypergrowth disruptor — it is an established, cash-generative franchise defending its core while attempting to cross-sell higher-value agreement automation and identity products. The current investor debate centers on whether DocuSign can reaccelerate growth from the high-single-digit range through AI-enabled contract intelligence and enterprise expansion, versus the bear case that its core e-signature business is a maturing, commoditizing utility facing pricing pressure and seat-based headwinds. Recent headlines capture this tension: the stock fell in June 2026 despite strong earnings and a raised long-term outlook as analysts trimmed targets on valuation and growth-pace concerns, yet the shares subsequently rallied sharply through the summer and autumn, suggesting the market has warmed to the margin story and capital-return program.…
DOCU
Docusign
$84.41
Related headlines
Investment Opinion: Should I buy DOCU Today?
Rating: Hold with a constructive bias. The core thesis is that DocuSign is a cash-generative, margin-expanding franchise trading at a discount to its own history (forward PE 14.33x, PS 3.27x, ~10% FCF yield), but revenue growth of 9.38% and a stock above the $69.99 average analyst target limit near-term upside. The consensus is neutral-to-cautious — 8 of 10 named analysts at Hold/Neutral, zero bearish, average target implying -6.2% downside — so the risk/reward is balanced rather than compelling at $74.65.
Supporting evidence: (1) forward PE of 14.33x versus trailing 34.57x implies substantial EPS expansion is already priced in, and consensus EPS of $5.73 is achievable if margins hold; (2) gross margin of 79.69% and operating margin of 13.43% (up from 8.15% a year ago) demonstrate best-in-class software economics with operating leverage; (3) trailing FCF of $1.20 billion against a ~$10.5-12.5 billion market cap yields roughly 9.6-11.4%, and $306.5 million of quarterly buybacks support EPS; (4) debt-to-equity of 0.0965 and interest coverage of 206.7x mean essentially no financial risk. Against this, PS of 3.27x is a discount to high-growth SaaS peers (5-10x) but is justified by high-single-digit growth, and the stock's 63.21% six-month gain has run past the average target.
Biggest risks that could invalidate the thesis: revenue growth decelerating below high-single digits, which would break the forward EPS bridge; multiple compression back toward the 2024-2025 de-rated regime; and competitive erosion in core e-signature. The rating would upgrade to Buy if the stock pulls back toward the $65 support zone (improving risk/reward) or if revenue growth accelerates into low-double digits with analyst target hikes above $80. It would downgrade to Sell if growth decelerates below 7% or if a cluster of downgrades pushes targets toward the $46.89 low. Valuation verdict: fairly valued to modestly undervalued relative to its own history and FCF yield, but not cheap relative to its growth rate — the stock is a value-GARP hybrid, not a bargain.
Sign up to view all
DOCU 12-Month Price Forecast
DocuSign presents a balanced risk/reward at $74.65: the valuation is undemanding on forward earnings and free cash flow, margins are expanding, and the balance sheet is fortress-like, but revenue growth of 9.38% is structurally modest and the stock has already run 63.21% in six months, past the average analyst target. The market has warmed to the margin and capital-return story, but the sell-side remains heavily Neutral, and the wide target range of $46.89-$86.00 signals genuine disagreement about the growth trajectory. I would upgrade to bullish if revenue growth accelerates into low-double digits or if the stock pulls back toward the $65 support zone, improving risk/reward. I would downgrade to bearish if growth decelerates below 7% or if a cluster of downgrades pushes targets toward the low end.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Docusign's 12-month outlook, with a consensus price target around $69.99 and implied upside of -17.1% versus the current price.
Average Target
$69.99
0 analysts
Implied Upside
-17.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$47 - $86
Analyst target range
Coverage is solid with 16 analysts, but sentiment is conspicuously neutral: the institutional ratings show a heavy skew toward Hold-equivalent stances, with Piper Sandler, Wells Fargo, Baird, Citigroup, RBC Capital, UBS, and Morgan Stanley all at Neutral/Equal Weight/Sector Perform, Needham at Hold, and only BTIG (Buy) and Citizens (Market Outperform) leaning positive — a distribution that is roughly 2 bullish, 8 neutral, and 0 bearish among the named firms, indicating analysts respect the franchise but see limited near-term upside. The consensus average target price is $69.99, which against the current price of $74.65 implies roughly -6.2% downside — the stock has run past the average analyst target, a classic signal that price momentum has outrun fundamental reassessment and that upgrades/target hikes are needed to sustain the move. The consensus therefore leans neutral-to-cautious, and the fact that the stock is trading above the mean target is a meaningful caution flag for momentum chasers. The target range is wide, from a low of $46.89 to a high of $86.00 — a spread of roughly 83% around the average — which signals high uncertainty and genuine disagreement about the growth trajectory. The high target of $86.00 (about +15.2% above the current price) likely assumes successful AI-driven product expansion, reacceleration toward low-double-digit growth, and continued multiple expansion on the back of the buyback and FCF yield; the low target of $46.89 (about -37.2% below current) prices in margin compression, competitive erosion in core e-signature, and a return to the de-rated multiple regime that dominated 2024-2025. The wide dispersion, combined with the recent pattern of analysts trimming targets after strong earnings (as seen in the June 2026 Benzinga headline), suggests the sell-side is lagging the price action and that estimate revisions — not current targets — will be the key catalyst; investors should watch for target hikes above $80 as confirmation of the re-rating, while a cluster of downgrades toward the low end would validate the bear case.
Bulls vs Bears: DOCU Investment Factors
The bull case currently has stronger evidence: a 14.3x forward PE, ~10% FCF yield, expanding margins, a fortress balance sheet, and powerful relative strength all point to a cash-generative franchise trading at a discount to its history. However, the bear case is not weak — revenue growth of 9.38% is structurally modest, the stock trades above the $69.99 average analyst target, and 8 of 10 named analysts are Neutral. The single most important tension is whether DocuSign can reaccelerate growth toward low-double digits through AI-enabled agreement automation and enterprise expansion, or whether the core e-signature business is a maturing utility whose multiple compression is deserved. Resolution of that growth question — not the margin story, which is already working — will determine whether the stock breaks above $78.80 or reverts toward the $60-65 consolidation zone.
Bullish
- Forward PE of 14.3x is strikingly cheap: The trailing PE of 34.57x collapses to a forward PE of just 14.33x based on consensus EPS of $5.73, implying the market expects earnings to more than double. If DocuSign delivers even close to that estimate, the stock is priced like a mature value name rather than a 79%-gross-margin software franchise.
- FCF yield near 10% with aggressive buybacks: Trailing free cash flow of $1.20 billion against a ~$10.5-12.5 billion market cap implies a 9.6-11.4% FCF yield, and the company repurchased $306.5 million of stock in the latest quarter alone, funded entirely by $334.5 million of operating cash flow. This capital-return engine provides a hard valuation floor and supports EPS growth independent of revenue acceleration.
- Margin expansion is real and accelerating: Operating margin expanded to 13.43% in the latest quarter from 8.15% a year ago, and net margin rose to 8.87% from 7.86%, despite revenue growing 9.38%. Operating expenses were essentially flat year over year ($580.25 million vs. $569.95 million) while revenue rose, demonstrating genuine operating leverage.
- Fortress balance sheet with minimal debt: Debt-to-equity is just 0.0965 and interest coverage is 206.7x, with $545.5 million in cash. This gives DocuSign substantial flexibility to sustain buybacks, invest in AI/agreement-automation products, or weather a downturn without dilution or refinancing risk.
Bearish
- Stock trades above analyst average target: The consensus average target is $69.99, implying roughly -6.2% downside from the current $74.65, and the stock has run past the mean target. With 8 of 10 named analysts at Neutral/Hold and zero bearish ratings, the sell-side is not yet endorsing the rally — upgrades and target hikes are needed to sustain it.
- Revenue growth stuck in high-single digits: Latest quarter revenue grew 9.38% year over year to $875.75 million, consistent with the prior quarters' high-single-digit pace ($830.24M, $836.86M, $818.35M). For a stock that once traded at 20x+ sales, this growth rate is the central bear argument and limits multiple expansion.
- Valuation multiple compression may be structural: The PS ratio has collapsed from 43.0x in Q4 FY2022 to 3.27x today, and the PE from 117x in early 2024 to 34.6x. While this looks like a value opportunity, it may reflect a permanent de-rating of a maturing growth story rather than a temporary dislocation.
- Core e-signature faces commoditization risk: Subscription revenue of $853.96 million dwarfs professional services at $21.79 million, meaning the entire growth engine depends on seat and tier expansion in a core product facing pricing pressure and seat-based headwinds. New agreement-automation and identity products have not yet proven they can lift growth into low-double digits.
DOCU Technical Analysis
DocuSign is in a powerful, sustained uptrend that has decisively reversed the prior downtrend: the stock is up 11.22% over the past year, but that headline understates the move because the current price of $74.65 sits at roughly 92% of its 52-week range (52-week low $40.16, 52-week high $78.80). That positioning near the top of the range signals momentum leadership rather than a value opportunity, though it also means the stock is extended and vulnerable to profit-taking — as evidenced by the -3.70% single-day pullback on the latest print from a $77.52 previous close. The 52-week range itself is wide (nearly a 96% spread from low to high), reflecting a stock that spent much of the year basing near $40-45 before breaking out. Recent momentum is strongly positive and accelerating on the intermediate horizon: +6.04% over one month, +41.54% over three months, and +63.21% over six months, with the 3-month and 6-month figures dramatically outpacing the 1-year gain of 11.22%. This pattern — modest 1-year return but explosive 3- and 6-month returns — indicates the bulk of gains came in a sharp second-half re-rating rather than steady compounding, and relative strength confirms it: DOCU has outperformed SPY by 38.85 percentage points over three months and 55.73 points over six months, though it lags SPY by 4.31 points over the full year. The 1-month gain of 6.04% versus SPY's 1.22% shows momentum is still intact but decelerating from the torrid 3-month pace, a classic late-stage-advance signature that warrants tighter risk management. Key levels are well defined: support sits at the 52-week low of $40.16, with intermediate support likely in the $60-65 zone where the stock consolidated in August-September, while resistance is the 52-week high of $78.80, just 5.6% above the current $74.65. A breakout above $78.80 on volume would confirm a new leg higher and likely trigger momentum-chasing flows, whereas a breakdown below $65 would break the sequence of higher lows and signal the rally is exhausting; the beta of 0.864 means the stock is roughly 14% less volatile than the market, which is unusual for a high-multiple software name and implies the recent move is idiosyncratic rather than beta-driven, though the max drawdown of -50.89% is a stark reminder of how violently this name can reverse.
Beta
0.86
0.86x market volatility
Max Drawdown
-50.9%
Largest decline past year
52-Week Range
$40-$85
Price range past year
Annual Return
+19.6%
Cumulative gain past year
| Period | DOCU Return | S&P 500 |
|---|---|---|
| 1m | +26.4% | -1.2% |
| 3m | +67.3% | +3.4% |
| 6m | +82.6% | +7.0% |
| 1y | +19.6% | +14.4% |
| ytd | +30.2% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DOCU Fundamental Analysis
Revenue is growing at a steady but modest pace: the most recent quarter (period ending 2026-07-31) delivered $875.75 million in revenue, up 9.38% year over year, and the multi-quarter trend shows consistent high-single-digit expansion — $830.24 million in the prior quarter, $836.86 million in Q4, $818.35 million in Q3, and $800.64 million in the year-ago Q2. Growth is stable rather than accelerating, which is the central issue for a stock that once traded at 20x+ sales; the composition is overwhelmingly subscription-driven, with subscription revenue of $853.96 million versus just $21.79 million in professional services and other, meaning the entire growth engine rests on seat and tier expansion in the core subscription base. The trajectory implies DocuSign has transitioned from a growth story to a durable, cash-generative compounder, and the investment case now hinges on whether new agreement-automation and identity products can lift growth back into low-double digits rather than on the core e-signature franchise, which appears mature. Profitability is solid and improving: net income was $77.72 million in the latest quarter (a 8.87% net margin), gross margin was a software-typical 79.69% (gross profit of $697.87 million on $875.75 million revenue), and operating income reached $117.62 million for a 13.43% operating margin. Margins have expanded meaningfully year over year — the year-ago Q2 posted a 7.86% net margin and 8.15% operating margin versus the current 8.87% and 13.43% — driven by operating expense discipline (operating expenses of $580.25 million against $569.95 million a year ago despite higher revenue) and a lower effective tax rate, and the trailing gross margin of 79.40% is consistent with best-in-class application software economics. The balance sheet is fortress-like and cash generation is exceptional: debt-to-equity is just 0.0965, interest coverage is a staggering 206.7x, and trailing free cash flow is $1.20 billion, which against a market cap of roughly $10.5-12.5 billion implies a free cash flow yield of roughly 9.6-11.4% — unusually high for a software company and the single most important support for the valuation. The company is aggressively returning capital, repurchasing $306.5 million of stock in the latest quarter alone (and $317.5 million in the prior quarter), funded entirely from operating cash flow of $334.5 million, while holding $545.5 million in cash; ROE of 16.12% and ROA of 6.35% are respectable, though the current ratio of 0.731 reflects a working-capital structure heavy on deferred revenue rather than a liquidity problem, and the low debt load means DocuSign has essentially no external financing dependence.
Quarterly Revenue
$875746000.0B
2026-07
Revenue YoY Growth
+9.4%
YoY Comparison
Gross Margin
79.7%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DOCU Overvalued?
Because DocuSign is profitable (net income of $77.72 million in the latest quarter, trailing EPS of $0.0293 on a GAAP basis but roughly $1.60+ on an adjusted basis), the PE ratio is the appropriate primary metric, and the trailing PE of 34.57x against a forward PE of just 14.33x is the most striking data point in the entire valuation picture. That enormous gap — forward earnings are expected to more than double relative to trailing — implies the market is pricing in substantial EPS expansion, likely driven by continued margin leverage, buyback-driven share reduction, and the analyst consensus EPS estimate of $5.73 for the forward period; if that estimate is even roughly achieved, the stock is cheap on a forward basis, but the gap also flags that trailing GAAP earnings are depressed by stock-based compensation and one-time items, so the forward multiple should be treated with skepticism until execution is confirmed. On peer comparison, the PS ratio of 3.27x and EV/Sales of 4.13x are modest for application software (many SaaS peers trade at 5-10x sales), while the EV/EBITDA of 22.40x and PCF of 9.04x are reasonable-to-attractive; the PEG ratio of -0.487 is not meaningful given the sign convention and should be disregarded, but the overall picture is that DocuSign trades at a discount to high-growth software peers on sales-based metrics, which is justified by its high-single-digit growth rate but arguably too harsh given its 79%+ gross margins and ~10% FCF yield. Historical context is revealing: the stock's PS ratio has compressed dramatically from 43.0x in Q4 FY2022 and 25.3x in Q4 FY2025 to 12.6x at Q4 FY2026 and now 3.27x, while the PE ratio has fallen from 117x in early 2024 to 34.6x today — the stock is near the bottom of its own historical valuation band on both sales and earnings multiples, which either signals a genuine value opportunity in a cash-rich, margin-expanding franchise or reflects the market's permanent de-rating of a maturing growth story. The bull case rests on the FCF yield and buyback; the bear case is that the multiple compression is deserved because growth has structurally slowed.
PE
34.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~117x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on growth dependence and working-capital structure. Revenue growth of 9.38% is the load-bearing assumption behind the 14.33x forward PE, which requires EPS to more than double from trailing levels; if growth decelerates toward mid-single digits, the forward estimate of $5.73 becomes vulnerable. The current ratio of 0.731 reflects a deferred-revenue-heavy working-capital structure rather than a liquidity problem, but it does mean the company relies on continued subscription collections to fund operations. Concentration is another risk: subscription revenue of $853.96 million versus $21.79 million in professional services means the entire growth engine rests on seat and tier expansion in the core e-signature base, leaving little diversification if that market commoditizes.
Market and competitive risks are dominated by valuation compression and commoditization. The stock trades at a PS of 3.27x and EV/Sales of 4.13x — modest for application software but justified only if growth holds; a further de-rating toward the 2024-2025 regime would compress the multiple even as earnings grow. Competition from workflow, contract lifecycle management, and identity-verification vendors threatens the core e-signature franchise with pricing pressure, and the beta of 0.864 means the stock is roughly 14% less volatile than the market, so recent gains are idiosyncratic rather than beta-driven and could reverse if the re-rating thesis falters. Recent news highlights the tension: the stock fell in June 2026 despite strong earnings and a raised long-term outlook as analysts trimmed targets on valuation and growth-pace concerns, and the sell-side remains heavily Neutral with the stock above the average target.
Worst-case scenario: growth decelerates below high-single digits, the forward EPS estimate of $5.73 proves unreachable, and the multiple compresses back toward the de-rated regime that dominated 2024-2025. In that chain, the stock could retest the 52-week low of $40.16, a decline of roughly -46% from the current $74.65, or fall toward the analyst low target of $46.89, about -37% downside. The max drawdown of -50.89% confirms this magnitude is historically plausible for this name. Investors should size positions recognizing that a -37% to -46% adverse scenario is a realistic tail risk, not a theoretical one.
FAQ
Ranked by severity: (1) Growth risk — revenue growth of 9.38% is the load-bearing assumption behind the 14.33x forward PE, and a deceleration below 7% would break the forward EPS estimate of $5.73 and likely compress the multiple. (2) Valuation compression risk — the PS of 3.27x could de-rate further toward the 2024-2025 regime if growth stalls, and the stock already trades above the $69.99 average target. (3) Competitive risk — core e-signature faces commoditization and pricing pressure from workflow and contract lifecycle vendors, and subscription revenue of $853.96 million is heavily concentrated in that core. (4) Technical/volatility risk — the stock is up 63.21% in six months, sits just 5.6% below its 52-week high, and has a max drawdown of -50.89%, so profit-taking could be violent.
The 12-month forecast has three scenarios: bull case (25% probability, $86-$90) assumes revenue growth accelerates to low-double digits and the stock breaks above $78.80; base case (50% probability, $65-$78) assumes high-single-digit growth with the stock consolidating between support and resistance; bear case (25% probability, $46.89-$55) assumes growth decelerates below 7% and the multiple compresses toward the analyst low target. The base case is most likely, with the key assumption being that revenue growth holds at 8-10% and operating margin stays at 13-14%. The wide target range of $46.89-$86.00 reflects genuine disagreement, and the average target of $69.99 implies modest downside from current levels.
DOCU is fairly valued to modestly undervalued relative to its own history but not cheap relative to its growth rate. The PS ratio of 3.27x is a fraction of the 43.0x seen in Q4 FY2022 and 12.6x at Q4 FY2026, and the trailing PE of 34.57x compares to 117x in early 2024, placing the stock near the bottom of its historical valuation band. On forward earnings, the 14.33x PE is undemanding for a 79%-gross-margin software franchise, and the ~10% FCF yield is unusually high for the sector. However, the market is paying a discount because growth is only 9.38%, and the stock has run past the $69.99 average target — the valuation implies the market expects EPS to more than double, which requires execution on margin leverage and buybacks.
From a risk/reward perspective, DOCU is a balanced proposition rather than a compelling buy at $74.65. The forward PE of 14.33x and ~10% FCF yield provide valuation support, and margins are expanding (operating margin 13.43% vs. 8.15% a year ago), but the stock trades above the $69.99 average analyst target, implying -6.2% downside to consensus, and 8 of 10 named analysts are Neutral. The biggest downside risk is a growth deceleration that breaks the forward EPS bridge, with the analyst low target of $46.89 representing ~-37% downside. It is a good buy for value-oriented investors with a 12-18 month horizon who can tolerate volatility, particularly on a pullback toward the $65 support zone; momentum chasers at current levels face unfavorable near-term risk/reward.
DOCU is better suited for medium-to-long-term holding (12-18 months minimum) than short-term trading. The growth stage is mature — revenue growth of 9.38% and a beta of 0.864 mean the stock is less volatile than the market on a beta basis, but the max drawdown of -50.89% and the 96% 52-week range show it can still swing violently. There is no dividend (payout ratio 0), so total return depends on EPS growth, buybacks, and multiple re-rating, which require time to play out. Earnings visibility is moderate given the stable subscription model, but the forward EPS estimate of $5.73 needs confirmation. Short-term traders should respect the $65 support and $78.80 resistance levels; long-term investors can accumulate on pullbacks toward $65.